| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Review Articles |
From the Department of Internal Medicine, Division of Allergy and Immunology, University of Michigan, Ann Arbor, Michigan
Abstract
Mastocytosis is a disease characterized by pathological mast cell accumulation and activation in tissues. Most patients with mastocytosis exhibit the D816V point mutation in the tyrosine kinase domain of the transmembrane receptor protein Kit, leading to its constitutive activation in bone marrow or lesional skin tissue. Detection of a codon 816 c-kit mutation is included as a minor diagnostic criterion in the World Health Organizations diagnostic criteria for systemic mastocytosis. Determining mutational status of the c-kit gene also has pharmacogenomic implications in patients considered for investigational mast cell cytoreductive therapies. This article reviews diagnostic and therapeutic implications of c-kit mutations as well as other less common molecular abnormalities observed in mast cell disease.
This article has been cited by other articles:
![]() |
S. Ogino and A. Goel Molecular Classification and Correlates in Colorectal Cancer J. Mol. Diagn., January 1, 2008; 10(1): 13 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Akin, L. M. Scott, C. N. Kocabas, N. Kushnir-Sukhov, E. Brittain, P. Noel, and D. D. Metcalfe Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis Blood, October 1, 2007; 110(7): 2331 - 2333. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Akin Targeting the mast cell: beyond KIT Blood, April 1, 2007; 109(7): 2674 - 2675. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |